MWM
Mascoma Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.95K | Hold |
40
| – | – | ﹤0.01% | 439 |
|
|
2025
Q1 | $1.36K | Buy |
+40
| New | +$1.36K | ﹤0.01% | 469 |
|
|
2024
Q3 | – | Sell |
-41
| Closed | -$2.21K | – | 469 |
|
|
2024
Q2 | $2.21K | Hold |
41
| – | – | ﹤0.01% | 459 |
|
|
2024
Q1 | $2.8K | Hold |
41
| – | – | ﹤0.01% | 419 |
|
|
2023
Q4 | $2.57K | Hold |
41
| – | – | ﹤0.01% | 435 |
|
|
2023
Q3 | $1.86K | Hold |
41
| – | – | ﹤0.01% | 467 |
|
|
2023
Q2 | $2.18K | Sell |
41
-250
| -86% | -$13.3K | ﹤0.01% | 444 |
|
|
2023
Q1 | $14.2K | Hold |
291
| – | – | ﹤0.01% | 369 |
|
|
2022
Q4 | $11.8K | Buy |
291
+41
| +16% | +$1.67K | ﹤0.01% | 389 |
|
|
2022
Q3 | $16K | Hold |
250
| – | – | 0.01% | 350 |
|
|
2022
Q2 | $15K | Hold |
250
| – | – | 0.01% | 373 |
|
|
2022
Q1 | $16K | Buy |
+250
| New | +$16K | 0.01% | 391 |
|